SkinHealth Systems Inc. (SKIN)
NASDAQ: SKIN · Real-Time Price · USD
16.31
+0.35 (2.19%)
Nov 13, 2026, 4:00 PM EST - Market closed

SkinHealth Systems Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, SkinHealth Systems stock has a consensus rating of "Hold" and an average price target of $14.5. The average 1-year stock price forecast is 11.10% lower than the current stock price, while the lowest is $10 (-38.69%) and the highest is $24 (+47.15%).

Price Target: $14.5 (-11.10%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price$10$14.5$12.5$24
Change-38.69%-11.10%-23.36%+47.15%

Analyst Ratings

The average analyst rating for SkinHealth Systems stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingApr '26May '26Jul '26Aug '26Oct '26Nov '26
Strong Buy111111
Buy000000
Hold666666
Sell222222
Strong Sell000000
Total999999

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
TD Cowen
TD Cowen
Hold
Maintains
$0.9 → $14
HoldMaintains$0.9 → $14-14.16%Nov 9, 2026
Canaccord Genuity
Canaccord Genuity
Hold
Reiterates
$11
HoldReiterates$11-32.56%Nov 9, 2026
Stifel Nicolaus
No rating
Stifel Nicolaus
Hold
Reiterates
$10
HoldReiterates$10-38.69%Nov 6, 2026
Jefferies
Jefferies
Hold
Maintains
$11
HoldMaintains$11-32.56%Oct 19, 2026
Roth MKM
Roth MKM
Buy
Reiterates
$50 → $40
BuyReiterates$50 → $40+145.25%May 20, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
285.17M
from 300.79M
Decreased by -5.19%
Revenue Next Year
288.89M
from 285.17M
Increased by 1.30%
EPS This Year
3.05
from 6.80
Decreased by -55.17%
EPS Next Year
4.48
from 3.05
Increased by 46.89%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
260.09M365.88M397.99M334.29M300.79M285.17M
Revenue Growth
118.39%40.68%8.78%-16.01%-10.02%-5.19%
Gross Profit
178.54M248.78M155.11M190.30M196.36M199.95M
Gross Margin
68.65%68.00%38.97%56.92%65.28%70.11%
Operating Income
-39.93M-25.84M-130.92M-59.77M-20.80M8.35M
Net Income
-378.76M44.22M-100.12M-29.10M-9.52M-13.94M
EPS
----6.803.05
EPS Growth
------55.17%
Forward PE
260.6447.0516.3142.509.125.35
Free Cash Flow
----32.30M9.10M
No. Analysts
-----9
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High286.9M
Avg285.2M
Low283.4M

Revenue Growth

Revenue Growth202620272028
High
-4.6%
Avg
-5.2%
Low
-5.8%

EPS Forecast

EPS202620272028
High3.05
Avg3.05
Low3.05

EPS Growth

EPS Growth202620272028
High
-55.2%
Avg
-55.2%
Low
-55.2%